ABSTRACT
@#Diabetes mellitus has reached epidemic levels in Malaysia due to increase in its risk factors such as obesity, dietary and sedentary lifestyle. In patients with uncontrolled diabetes mellitus, diabetic foot ulcer (DFU)is a common complication. Managing diabetic foot infection is often multifactorial and intricate. The management DFU demands multi-speciality approach and often tedious. Hyperbaric oxygen therapy (HBOT) is a promising adjunctive treatment used to enhance the healing process plus reduces cost and recovery time. This is a case of a 52 years old lady, with underlying poorly diabetes mellitus, who presented with diabetic foot ulcer Wagner IV classification in sepsis. She underwent trans-metatarsal amputation followed by split skin grafting with additional adjunctive HBOT in a tertiary hospital.
ABSTRACT
Introduction: Acute acoustic trauma, which is a kind of sensorineural hearing loss, is caused by acoustic overstimulation. Hyperbaric oxygen therapy (HBOT) is reported to be effective against acute acoustic trauma. Objective: We aimed to evaluate the efficacy of HBOT against acoustic hearing loss based on our 20 years of experience with such cases. Methods: Patients who were treated with HBOT for acute acoustic trauma between April 1997 and August 2017 were evaluated in this study. Thirty-five patients with a mean age of 25.7 ± 9.2 (range: 1648) years were included. Thirty-nine out of 70 ears (35 patients) were damaged. We investigated the initial level of hearing loss; the extent to which hearing recovered; subjective symptoms, such as tinnitus and aural fullness; and the treatment administered. Results: The planned HBOT was completed in 37 of 39 ears. Twenty-six of the 37 ears (70.2%) displayed improved hearing, and 31 of the 37 ears (83.9%) exhibited symptom improvement. Twenty-three (76.7%) and 26 (86.7%) of the 30 ears treated with steroids demonstrated improvements in hearing and subjective symptoms, respectively. Conclusion: A combination of HBOT and steroids should be considered as a treatment for acute acoustic trauma in cases involving symptoms such as tinnitus and aural fullness (AU)
Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Hearing Loss, Noise-Induced/therapy , Hyperbaric Oxygenation , Steroids/therapeutic use , Tinnitus/therapy , Treatment Outcome , Hearing Loss, Sensorineural/therapy , Hearing Tests , Hospitals, Military , JapanABSTRACT
El uso clínico de la terapia de oxigenación hiperbárica (TOHB) consiste en respirar oxígeno en una concentración cercana al 100% en una cámara presurizada al menos a 1,4 atmósferas absolutas (atm). TOHB actúa produciendo hiperoxia y especies reactivas del oxígeno que desencadenan mecanismos bioquímicos variados. Se presenta una revisión de todas las nuevas aplicaciones emergentes de TOHB en varias especialidades médicas debido a que alcanza beneficios en la cicatrización de heridas, enfermedades inflamatorias y con componente neurológico o isquémico. Las nuevas cámaras realizan el tratamiento a presiones más seguras y con la misma eficiencia demostrada por métodos matemáticos y bioquímicos. El Grupo BioBárica Clinical Research presenta la estadística de las indicaciones en 559 pacientes tratados con estas cámaras en algunos centros médicos y las especialidades médicas implicadas. El uso de TOHB a media presión está en emergencia y podría proveer a futuro evidencia de su efectividad en otras especialidades médicas. (AU)
The clinical use of Hyperbaric Oxygen Therapy (HBOT) consists in breathing oxygen (O2) near to 100% in a pressurized chamber of at least at 1.4 absolute atmospheres (ATA). HBOT acts producing both hyperoxia and reactive oxygen species (ROS) and triggers others biochemical events. The BioBarica Clinical Research Group is developing clinical evidence in diverse pathologies because of accessibility and safety of the new Revitalair hyperbaric oxygen chamber. Because of working at "mild pressure", HBOT performed by these chamber are safer demonstrated by mathematical and biochemical methods. The BioBarica Clinical Research Group presents the statistics of the indications in 559 patients treated with these cameras in some medical centers and the medical specialties involved. Their accessibility to the physicians would become mild pressure HBOT used more frequently proving its effectiveness in other clinical specialties. (AU)
Subject(s)
Humans , Treatment Outcome , Contraindications, Procedure , Hyperbaric Oxygenation/instrumentation , Hyperbaric Oxygenation/methods , Wounds and Injuries/therapy , Carbon Monoxide Poisoning/therapy , Rheumatic Diseases/therapy , Diabetic Foot/therapy , Physical Conditioning, Human/methods , Neoplasms/therapyABSTRACT
Background: The purpose of this study was to test the effectiveness and safety of Hyperbaric Oxygen HBOT group (HBOT) in improving brain function in Traumatic brain injury patients suffering acute neurocognitive impairments. Aims: To study efficacy & safety of hyperbaric oxygen HBOT group on mortality and morbidity in acute traumatic brain injury with respect to degree of recovery, speed of recovery, length of stay in the hospital. Methods: In this prospective study we present 100 cases of head injuries. Patients were included in the study according to inclusion criteria. Fifty of them assigned to the control group and 50 to the HBO treatment group. Allocation is done by chit method in control and HBOT group. Glasgow coma score was obtained pre HBOT and post HBOT. The outcome was assessed by two blinded independent examiners. Results: All patients were assessed for improvement in GCS score. The average improvement in GCS score was 5.29% and 3.87% in HBOT and control group respectively. Similarly the average hospital stay was 12.26% days in the HBOT and 27% in the control group. Conclusion: Hence we would like to conclude that, HBOT is safe and effective for acute brain injury.